bioMérieux - 2011 Financial Results

13 March, 2012

The Board of Directors of bioMérieux, a global leader in the field of in vitro diagnostics, met today and approved the consolidated financial statements for the year ended December 31, 2011. The meeting was chaired by Jean-Luc Belingard and attended by the Statutory Auditors, who have audited the financial statements and will be issuing an unqualified opinion in the coming days.

Solid financial performance:

  • Sales at constant exchange rates: up 6.5%
  • Including organic growth: up 4.1%
  • Operating margin before non-recurring items: 18%

Confirmed medium and long-term growth potential, supported by:

  • Innovation and a robust product pipeline
  • International expansion
  • Targeted acquisitions and partnerships

 

Pioneering Diagnostics